{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:48:58Z","timestamp":1790740138328,"version":"4.1.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Chinese Research Council","award":["scholarship"],"award-info":[{"award-number":["scholarship"]}]},{"name":"DFG","award":["DFG KO 3598\/5-1"],"award-info":[{"award-number":["DFG KO 3598\/5-1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Blood metabolites of the tryptophan pathway were found to be associated with kidney function and disease in observational studies. In order to evaluate causal relationship and direction, we designed a study using a bidirectional Mendelian randomization approach. The analyses were based on published summary statistics with study sizes ranging from 1,960 to 133,413. After correction for multiple testing, results provided no evidence of an effect of metabolites of the tryptophan pathway on estimated glomerular filtration rate (eGFR). Conversely, lower eGFR was related to higher levels of four metabolites: C-glycosyltryptophan (effect estimate\u2009=\u2009\u2212\u00a00.16, 95% confidence interval [CI] (\u2212\u00a00.22; \u2212\u00a00.1);\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20099.2e\u221208), kynurenine (effect estimate\u2009=\u2009\u2212\u00a00.18, 95% CI (\u2212\u00a00.25; \u2212\u00a00.11);\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20091.1e\u221206), 3-indoxyl sulfate (effect estimate\u2009=\u2009\u2212\u00a00.25, 95% CI (\u2212\u00a00.4; \u2212\u00a00.11);\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20096.3e\u221204) and indole-3-lactate (effect estimate\u2009=\u2009\u2212\u00a00.26, 95% CI (\u2212\u00a00.38; \u2212\u00a00.13);\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20095.4e\u221205). Our study supports that lower eGFR causes higher blood metabolite levels of the tryptophan pathway including kynurenine, C-glycosyltryptophan, 3-indoxyl sulfate, and indole-3-lactate. These findings aid the notion that metabolites of the tryptophan pathway are a consequence rather than a cause of reduced eGFR. Further research is needed to specifically examine relationships with respect to chronic kidney disease (CKD) progression among patients with existing CKD.\n                  <\/jats:p>","DOI":"10.1038\/s41598-020-69559-x","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T06:04:12Z","timestamp":1596002652000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["The relationship between blood metabolites of the tryptophan pathway and kidney function: a bidirectional Mendelian randomization analysis"],"prefix":"10.1038","volume":"10","author":[{"given":"Yurong","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Benkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Lamina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"K\u00f6ttgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy","family":"Sekula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,29]]},"reference":[{"key":"69559_CR1","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1056\/NEJMra054415","volume":"354","author":"LA Stevens","year":"2006","unstructured":"Stevens, L. A., Coresh, J., Greene, T. & Levey, A. S. Assessing kidney function\u2013measured and estimated glomerular filtration rate. N. Engl. J. Med. 354, 2473\u20132483. https:\/\/doi.org\/10.1056\/NEJMra054415 (2006).","journal-title":"N. Engl. J. Med."},{"key":"69559_CR2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S0140-6736(13)60439-0","volume":"382","author":"KU Eckardt","year":"2013","unstructured":"Eckardt, K. U. et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet 382, 158\u2013169. https:\/\/doi.org\/10.1016\/S0140-6736(13)60439-0 (2013).","journal-title":"Lancet"},{"key":"69559_CR3","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/S0140-6736(17)30788-2","volume":"390","author":"A Levin","year":"2017","unstructured":"Levin, A. et al. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet 390, 1888\u20131917. https:\/\/doi.org\/10.1016\/S0140-6736(17)30788-2 (2017).","journal-title":"Lancet"},{"key":"69559_CR4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrneph.2017.30","volume":"13","author":"B Hocher","year":"2017","unstructured":"Hocher, B. & Adamski, J. Metabolomics for clinical use and research in chronic kidney disease. Nat. Rev. Nephrol. 13, 269\u2013284. https:\/\/doi.org\/10.1038\/nrneph.2017.30 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"69559_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.semnephrol.2018.01.009","volume":"38","author":"A Kottgen","year":"2018","unstructured":"Kottgen, A., Raffler, J., Sekula, P. & Kastenmuller, G. Genome-wide association studies of metabolite concentrations (mGWAS): relevance for nephrology. Semin. Nephrol. 38, 151\u2013174. https:\/\/doi.org\/10.1016\/j.semnephrol.2018.01.009 (2018).","journal-title":"Semin. Nephrol."},{"key":"69559_CR6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.semnephrol.2018.01.005","volume":"38","author":"EP Rhee","year":"2018","unstructured":"Rhee, E. P. A systems-level view of renal metabolomics. Semin. Nephrol. 38, 142\u2013150. https:\/\/doi.org\/10.1016\/j.semnephrol.2018.01.005 (2018).","journal-title":"Semin. Nephrol."},{"key":"69559_CR7","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1038\/nprot.2007.376","volume":"2","author":"O Beckonert","year":"2007","unstructured":"Beckonert, O. et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat. Protoc. 2, 2692\u20132703. https:\/\/doi.org\/10.1038\/nprot.2007.376 (2007).","journal-title":"Nat. Protoc."},{"key":"69559_CR8","first-page":"1","volume":"4","author":"A Evans","year":"2014","unstructured":"Evans, A. et al. High resolution mass spectrometry improves data quantity and quality as compared to unit mass resolution mass spectrometry in high-throughput profiling metabolomics. Metabolomics 4, 1 (2014).","journal-title":"Metabolomics"},{"key":"69559_CR9","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrm.2016.25","volume":"17","author":"CH Johnson","year":"2016","unstructured":"Johnson, C. H., Ivanisevic, J. & Siuzdak, G. Metabolomics: beyond biomarkers and towards mechanisms. Nat. Rev. Mol. Cell. Biol. 17, 451\u2013459. https:\/\/doi.org\/10.1038\/nrm.2016.25 (2016).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"69559_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/978-1-4684-5952-4_32","volume":"294","author":"JC Peters","year":"1991","unstructured":"Peters, J. C. Tryptophan nutrition and metabolism: an overview. Adv. Exp. Med. Biol. 294, 345\u2013358. https:\/\/doi.org\/10.1007\/978-1-4684-5952-4_32 (1991).","journal-title":"Adv. Exp. Med. Biol."},{"key":"69559_CR11","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1365-2982.2009.01370.x","volume":"21","author":"D Keszthelyi","year":"2009","unstructured":"Keszthelyi, D., Troost, F. J. & Masclee, A. A. Understanding the role of tryptophan and serotonin metabolism in gastrointestinal function. Neurogastroenterol. Motil. 21, 1239\u20131249. https:\/\/doi.org\/10.1111\/j.1365-2982.2009.01370.x (2009).","journal-title":"Neurogastroenterol. Motil."},{"key":"69559_CR12","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1007\/s00216-011-5436-y","volume":"401","author":"W Zhu","year":"2011","unstructured":"Zhu, W. et al. Quantitative profiling of tryptophan metabolites in serum, urine, and cell culture supernatants by liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem. 401, 3249\u20133261. https:\/\/doi.org\/10.1007\/s00216-011-5436-y (2011).","journal-title":"Anal. Bioanal. Chem."},{"key":"69559_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/MCO.0000000000000237","volume":"19","author":"B Strasser","year":"2016","unstructured":"Strasser, B., Gostner, J. M. & Fuchs, D. Mood, food, and cognition: role of tryptophan and serotonin. Curr. Opin. Clin. Nutr. Metab. Care 19, 55\u201361. https:\/\/doi.org\/10.1097\/MCO.0000000000000237 (2016).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"69559_CR14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1053\/j.ajkd.2012.01.014","volume":"60","author":"ON Goek","year":"2012","unstructured":"Goek, O. N. et al. Serum metabolite concentrations and decreased GFR in the general population. Am. J. Kidney Dis. 60, 197\u2013206. https:\/\/doi.org\/10.1053\/j.ajkd.2012.01.014 (2012).","journal-title":"Am. J. Kidney Dis."},{"key":"69559_CR15","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1093\/ndt\/gft217","volume":"28","author":"ON Goek","year":"2013","unstructured":"Goek, O. N. et al. Metabolites associate with kidney function decline and incident chronic kidney disease in the general population. Nephrol. Dial Transplant 28, 2131\u20132138. https:\/\/doi.org\/10.1093\/ndt\/gft217 (2013).","journal-title":"Nephrol. Dial Transplant"},{"key":"69559_CR16","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1681\/ASN.2014111099","volume":"27","author":"P Sekula","year":"2016","unstructured":"Sekula, P. et al. A metabolome-wide association study of kidney function and disease in the general population. J Am Soc Nephrol 27, 1175\u20131188. https:\/\/doi.org\/10.1681\/ASN.2014111099 (2016).","journal-title":"J Am Soc Nephrol"},{"key":"69559_CR17","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1681\/asn.2016010098","volume":"27","author":"P Sekula","year":"2016","unstructured":"Sekula, P., Del Greco, M. F., Pattaro, C. & Kottgen, A. Mendelian randomization as an approach to assess causality using observational data. J. Am Soc. Nephrol. 27, 3253\u20133265. https:\/\/doi.org\/10.1681\/asn.2016010098 (2016).","journal-title":"J. Am Soc. Nephrol."},{"key":"69559_CR18","doi-asserted-by":"publisher","first-page":"F226","DOI":"10.1152\/ajprenal.00567.2007","volume":"295","author":"K Mohib","year":"2008","unstructured":"Mohib, K. et al. Indoleamine 2,3-dioxygenase expression promotes renal ischemia-reperfusion injury. Am. J. Physiol. Renal. Physiol. 295, F226-234. https:\/\/doi.org\/10.1152\/ajprenal.00567.2007 (2008).","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"69559_CR19","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1681\/ASN.2015070835","volume":"27","author":"R Korstanje","year":"2016","unstructured":"Korstanje, R. et al. Loss of Kynurenine 3-mono-oxygenase causes proteinuria. J. Am. Soc. Nephrol. 27, 3271\u20133277. https:\/\/doi.org\/10.1681\/ASN.2015070835 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"69559_CR20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/glycob\/cwi012","volume":"15","author":"Y Ihara","year":"2005","unstructured":"Ihara, Y. et al. Increased expression of protein C-mannosylation in the aortic vessels of diabetic Zucker rats. Glycobiology 15, 383\u2013392. https:\/\/doi.org\/10.1093\/glycob\/cwi012 (2005).","journal-title":"Glycobiology"},{"key":"69559_CR21","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/S0002-9343(00)00693-8","volume":"110","author":"R Takahira","year":"2001","unstructured":"Takahira, R. et al. Tryptophan glycoconjugate as a novel marker of renal function. Am. J. Med. 110, 192\u2013197. https:\/\/doi.org\/10.1016\/S0002-9343(00)00693-8 (2001).","journal-title":"Am. J. Med."},{"key":"69559_CR22","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s00216-013-7472-2","volume":"406","author":"T Kobayashi","year":"2014","unstructured":"Kobayashi, T. et al. Exploration of novel predictive markers in rat plasma of the early stages of chronic renal failure. Anal. Bioanal. Chem. 406, 1365\u20131376. https:\/\/doi.org\/10.1007\/s00216-013-7472-2 (2014).","journal-title":"Anal. Bioanal. Chem."},{"key":"69559_CR23","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/sim.3034","volume":"27","author":"DA Lawlor","year":"2008","unstructured":"Lawlor, D. A., Harbord, R. M., Sterne, J. A. C., Timpson, N. & Smith, G. D. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat. Med. 27, 1133\u20131163. https:\/\/doi.org\/10.1002\/sim.3034 (2008).","journal-title":"Stat. Med."},{"key":"69559_CR24","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/aje\/kwt084","volume":"178","author":"BL Pierce","year":"2013","unstructured":"Pierce, B. L. & Burgess, S. Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators. Am J Epidemiol 178, 1177\u20131184. https:\/\/doi.org\/10.1093\/aje\/kwt084 (2013).","journal-title":"Am J Epidemiol"},{"key":"69559_CR25","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/s41588-019-0407-x","volume":"51","author":"M Wuttke","year":"2019","unstructured":"Wuttke, M. et al. A catalog of genetic loci associated with kidney function from analyses of a million individuals. Nat. Genet. 51, 957\u2013972. https:\/\/doi.org\/10.1038\/s41588-019-0407-x (2019).","journal-title":"Nat. Genet."},{"key":"69559_CR26","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1002\/sim.6835","volume":"35","author":"S Burgess","year":"2016","unstructured":"Burgess, S., Dudbridge, F. & Thompson, S. G. Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods. Stat. Med. 35, 1880\u20131906. https:\/\/doi.org\/10.1002\/sim.6835 (2016).","journal-title":"Stat. Med."},{"key":"69559_CR27","doi-asserted-by":"publisher","first-page":"F565","DOI":"10.1152\/ajprenal.2000.279.3.F565","volume":"279","author":"K Saito","year":"2000","unstructured":"Saito, K. et al. Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency. Am. J. Physiol. Renal. Physiol 279, F565-572. https:\/\/doi.org\/10.1152\/ajprenal.2000.279.3.F565 (2000).","journal-title":"Am. J. Physiol. Renal. Physiol"},{"key":"69559_CR28","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","volume":"63","author":"R Vanholder","year":"2003","unstructured":"Vanholder, R. et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 63, 1934\u20131943. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00924.x (2003).","journal-title":"Kidney Int."},{"key":"69559_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/toxins10060226","volume":"10","author":"RD Mair","year":"2018","unstructured":"Mair, R. D., Sirich, T. L. & Meyer, T. W. Uremic toxin clearance and cardiovascular toxicities. Toxins 10, 1. https:\/\/doi.org\/10.3390\/toxins10060226 (2018).","journal-title":"Toxins"},{"key":"69559_CR30","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.bbrc.2014.02.021","volume":"445","author":"T Kobayashi","year":"2014","unstructured":"Kobayashi, T. et al. A metabolomics-based approach for predicting stages of chronic kidney disease. Biochem. Biophys. Res. Commun. 445, 412\u2013416. https:\/\/doi.org\/10.1016\/j.bbrc.2014.02.021 (2014).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"69559_CR31","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1093\/ndt\/gfn739","volume":"24","author":"JC Schefold","year":"2009","unstructured":"Schefold, J. C. et al. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms. Nephrol. Dial Transplant 24, 1901\u20131908. https:\/\/doi.org\/10.1093\/ndt\/gfn739 (2009).","journal-title":"Nephrol. Dial Transplant"},{"key":"69559_CR32","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1681\/ASN.2009111132","volume":"21","author":"EP Rhee","year":"2010","unstructured":"Rhee, E. P. et al. Metabolite profiling identifies markers of uremia. J. Am. Soc. Nephrol. 21, 1041\u20131051. https:\/\/doi.org\/10.1681\/ASN.2009111132 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"69559_CR33","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/hr.2010.113","volume":"33","author":"T Toyohara","year":"2010","unstructured":"Toyohara, T. et al. Metabolomic profiling of uremic solutes in CKD patients. Hypertens. Res. 33, 944\u2013952. https:\/\/doi.org\/10.1038\/hr.2010.113 (2010).","journal-title":"Hypertens. Res."},{"key":"69559_CR34","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1681\/ASN.2012101006","volume":"24","author":"EP Rhee","year":"2013","unstructured":"Rhee, E. P. et al. A combined epidemiologic and metabolomic approach improves CKD prediction. J. Am. Soc. Nephrol. 24, 1330\u20131338. https:\/\/doi.org\/10.1681\/ASN.2012101006 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"69559_CR35","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.redox.2017.03.017","volume":"12","author":"DQ Chen","year":"2017","unstructured":"Chen, D. Q. et al. Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt\/beta-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease. Redox. Biol. 12, 505\u2013521. https:\/\/doi.org\/10.1016\/j.redox.2017.03.017 (2017).","journal-title":"Redox. Biol."},{"key":"69559_CR36","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/MNH.0b013e32834b8a1d","volume":"20","author":"EP Rhee","year":"2011","unstructured":"Rhee, E. P. & Thadhani, R. New insights into uremia-induced alterations in metabolic pathways. Curr. Opin. Nephrol. Hy 20, 593\u2013598. https:\/\/doi.org\/10.1097\/MNH.0b013e32834b8a1d (2011).","journal-title":"Curr. Opin. Nephrol. Hy"},{"key":"69559_CR37","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.abb.2015.07.018","volume":"589","author":"M Breit","year":"2016","unstructured":"Breit, M. & Weinberger, K. M. Metabolic biomarkers for chronic kidney disease. Arch. Biochem. Biophys. 589, 62\u201380. https:\/\/doi.org\/10.1016\/j.abb.2015.07.018 (2016).","journal-title":"Arch. Biochem. Biophys."},{"key":"69559_CR38","doi-asserted-by":"publisher","first-page":"117864691769460","DOI":"10.1177\/1178646917694600","volume":"10","author":"S Debnath","year":"2017","unstructured":"Debnath, S. et al. Tryptophan metabolism in patients with chronic kidney disease secondary to type 2 diabetes: relationship to inflammatory markers. Int. J. Tryptophan. Res. 10, 1178646917694600. https:\/\/doi.org\/10.1177\/1178646917694600 (2017).","journal-title":"Int. J. Tryptophan. Res."},{"key":"69559_CR39","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.atherosclerosis.2008.08.014","volume":"204","author":"K Pawlak","year":"2009","unstructured":"Pawlak, K., Domaniewski, T., Mysliwiec, M. & Pawlak, D. The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease. Atherosclerosis 204, 309\u2013314. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2008.08.014 (2009).","journal-title":"Atherosclerosis"},{"key":"69559_CR40","doi-asserted-by":"publisher","first-page":"465","DOI":"10.5414\/cnp74465","volume":"74","author":"P Koenig","year":"2010","unstructured":"Koenig, P. et al. Enhanced degradation of tryptophan in patients on hemodialysis. Clin. Nephrol 74, 465\u2013470. https:\/\/doi.org\/10.5414\/cnp74465 (2010).","journal-title":"Clin. Nephrol"},{"key":"69559_CR41","doi-asserted-by":"publisher","first-page":"327","DOI":"10.12659\/AOT.893721","volume":"20","author":"J Kaden","year":"2015","unstructured":"Kaden, J., Abendroth, D., Volp, A. & Marzinzig, M. Dynamics and diagnostic relevance of Kynurenine serum level after kidney transplantation. Ann. Transplant 20, 327\u2013337. https:\/\/doi.org\/10.12659\/AOT.893721 (2015).","journal-title":"Ann. Transplant"},{"key":"69559_CR42","doi-asserted-by":"crossref","unstructured":"42de Vries, L. V. et al. The tryptophan\/kynurenine pathway, systemic inflammation, and long-term outcome after kidney transplantation. Am J Physiol Renal Physiol 313, F475-F486, doi:10.1152\/ajprenal.00690.2016 (2017).","DOI":"10.1152\/ajprenal.00690.2016"},{"key":"69559_CR43","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1073\/pnas.1719190115","volume":"115","author":"MT Nelp","year":"2018","unstructured":"Nelp, M. T. et al. Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form. Proc. Natl. Acad. Sci. U S A 115, 3249\u20133254. https:\/\/doi.org\/10.1073\/pnas.1719190115 (2018).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"69559_CR44","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.2174\/0929867325666180307110908","volume":"25","author":"AL Saucedo","year":"2018","unstructured":"Saucedo, A. L. et al. Chronic kidney disease and the search for new biomarkers for early diagnosis. Curr. Med. Chem. 25, 3719\u20133747. https:\/\/doi.org\/10.2174\/0929867325666180307110908 (2018).","journal-title":"Curr. Med. Chem."},{"key":"69559_CR45","doi-asserted-by":"publisher","first-page":"781","DOI":"10.18388\/abp.2000_3996","volume":"47","author":"A Furmanek","year":"2000","unstructured":"Furmanek, A. & Hofsteenge, J. Protein C-mannosylation: facts and questions. Acta Biochim. Pol. 47, 781\u2013789 (2000).","journal-title":"Acta Biochim. Pol."},{"key":"69559_CR46","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1002\/chem.200390163","volume":"9","author":"S Manabe","year":"2003","unstructured":"Manabe, S., Marui, Y. & Ito, Y. Total synthesis of mannosyl tryptophan and its derivatives. Chemistry 9, 1435\u20131447. https:\/\/doi.org\/10.1002\/chem.200390163 (2003).","journal-title":"Chemistry"},{"key":"69559_CR47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1515\/cclm-2012-0880","volume":"52","author":"P Gillery","year":"2014","unstructured":"Gillery, P. & Jaisson, S. Post-translational modification derived products (PTMDPs): toxins in chronic diseases?. Clin. Chem. Lab. Med. 52, 33\u201338. https:\/\/doi.org\/10.1515\/cclm-2012-0880 (2014).","journal-title":"Clin. Chem. Lab. Med."},{"key":"69559_CR48","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2215\/CJN.05540512","volume":"8","author":"VO Shah","year":"2013","unstructured":"Shah, V. O. et al. Plasma metabolomic profiles in different stages of CKD. Clin. J. Am. Soc. Nephrol. 8, 363\u2013370. https:\/\/doi.org\/10.2215\/CJN.05540512 (2013).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"69559_CR49","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/ki.2013.497","volume":"85","author":"MA Niewczas","year":"2014","unstructured":"Niewczas, M. A. et al. Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study. Kidney Int. 85, 1214\u20131224. https:\/\/doi.org\/10.1038\/ki.2013.497 (2014).","journal-title":"Kidney Int."},{"key":"69559_CR50","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1210\/jc.2015-3345","volume":"101","author":"A Solini","year":"2016","unstructured":"Solini, A. et al. Prediction of declining renal function and albuminuria in patients with type 2 diabetes by metabolomics. J. Clin. Endocrinol. Metab. 101, 696\u2013704. https:\/\/doi.org\/10.1210\/jc.2015-3345 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"69559_CR51","doi-asserted-by":"publisher","first-page":"17400","DOI":"10.1038\/s41598-017-17107-5","volume":"7","author":"P Sekula","year":"2017","unstructured":"Sekula, P. et al. From discovery to translation: characterization of C-mannosyltryptophan and pseudouridine as markers of kidney function. Sci. Rep. 7, 17400. https:\/\/doi.org\/10.1038\/s41598-017-17107-5 (2017).","journal-title":"Sci. Rep."},{"key":"69559_CR52","doi-asserted-by":"publisher","first-page":"13853","DOI":"10.1038\/s41598-018-32085-y","volume":"8","author":"JK Haukka","year":"2018","unstructured":"Haukka, J. K. et al. Metabolomic profile predicts development of microalbuminuria in individuals with type 1 diabetes. Sci. Rep. 8, 13853. https:\/\/doi.org\/10.1038\/s41598-018-32085-y (2018).","journal-title":"Sci. Rep."},{"key":"69559_CR53","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1111\/j.1523-1755.2004.00521.x","volume":"65","author":"K Yonemura","year":"2004","unstructured":"Yonemura, K., Takahira, R., Yonekawa, O., Wada, N. & Hishida, A. The diagnostic value of serum concentrations of 2-(alpha-mannopyranosyl)-L-tryptophan for normal renal function. Kidney Int. 65, 1395\u20131399. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00521.x (2004).","journal-title":"Kidney Int."},{"key":"69559_CR54","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2337\/dc16-0173","volume":"40","author":"MA Niewczas","year":"2017","unstructured":"Niewczas, M. A. et al. Circulating modified metabolites and a risk of ESRD in patients with type 1 diabetes and chronic kidney disease. Diabetes Care 40, 383\u2013390. https:\/\/doi.org\/10.2337\/dc16-0173 (2017).","journal-title":"Diabetes Care"},{"key":"69559_CR55","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.chom.2016.10.021","volume":"20","author":"AS Devlin","year":"2016","unstructured":"Devlin, A. S. et al. Modulation of a circulating uremic solute via rational genetic manipulation of the gut microbiota. Cell Host. Microbe. 20, 709\u2013715. https:\/\/doi.org\/10.1016\/j.chom.2016.10.021 (2016).","journal-title":"Cell Host. Microbe."},{"key":"69559_CR56","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fcimb.2018.00013","volume":"8","author":"J Gao","year":"2018","unstructured":"Gao, J. et al. Impact of the gut microbiota on intestinal immunity mediated by tryptophan metabolism. Front. Cell Infect. Microbiol. 8, 13. https:\/\/doi.org\/10.3389\/fcimb.2018.00013 (2018).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"69559_CR57","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1681\/ASN.2013080905","volume":"25","author":"A Ramezani","year":"2014","unstructured":"Ramezani, A. & Raj, D. S. The gut microbiome, kidney disease, and targeted interventions. J. Am. Soc. Nephrol. 25, 657\u2013670. https:\/\/doi.org\/10.1681\/ASN.2013080905 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"69559_CR58","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40168-016-0195-9","volume":"4","author":"J Crespo-Salgado","year":"2016","unstructured":"Crespo-Salgado, J. et al. Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study. Microbiome 4, 50. https:\/\/doi.org\/10.1186\/s40168-016-0195-9 (2016).","journal-title":"Microbiome"},{"key":"69559_CR59","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1113\/EP085283","volume":"101","author":"MR Wing","year":"2016","unstructured":"Wing, M. R., Patel, S. S., Ramezani, A. & Raj, D. S. Gut microbiome in chronic kidney disease. Exp. Physiol. 101, 471\u2013477. https:\/\/doi.org\/10.1113\/EP085283 (2016).","journal-title":"Exp. Physiol."},{"key":"69559_CR60","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00467-016-3392-7","volume":"32","author":"S Al Khodor","year":"2017","unstructured":"Al Khodor, S. & Shatat, I. F. Gut microbiome and kidney disease: a bidirectional relationship. Pediatr Nephrol 32, 921\u2013931. https:\/\/doi.org\/10.1007\/s00467-016-3392-7 (2017).","journal-title":"Pediatr Nephrol"},{"key":"69559_CR61","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11906-017-0727-0","volume":"19","author":"RG Armani","year":"2017","unstructured":"Armani, R. G. et al. Gut microbiome in chronic kidney disease. Curr Hypertens Rep 19, 29. https:\/\/doi.org\/10.1007\/s11906-017-0727-0 (2017).","journal-title":"Curr Hypertens Rep"},{"key":"69559_CR62","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11892-018-1064-7","volume":"18","author":"L Koppe","year":"2018","unstructured":"Koppe, L., Fouque, D. & Soulage, C. O. Metabolic abnormalities in diabetes and kidney disease: role of uremic toxins. Curr. Diab. Rep. 18, 97. https:\/\/doi.org\/10.1007\/s11892-018-1064-7 (2018).","journal-title":"Curr. Diab. Rep."},{"issue":"Suppl 4","key":"69559_CR63","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/nep.13452","volume":"23","author":"CY Yang","year":"2018","unstructured":"Yang, C. Y. & Tarng, D. C. Diet, gut microbiome and indoxyl sulphate in chronic kidney disease patients. Nephrology (Carlton) 23(Suppl 4), 16\u201320. https:\/\/doi.org\/10.1111\/nep.13452 (2018).","journal-title":"Nephrology (Carlton)"},{"key":"69559_CR64","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/advances\/nmy068","volume":"10","author":"M Snelson","year":"2019","unstructured":"Snelson, M., Kellow, N. J. & Coughlan, M. T. Modulation of the gut microbiota by resistant starch as a treatment of chronic kidney diseases: evidence of efficacy and mechanistic insights. Adv. Nutr. 10, 303\u2013320. https:\/\/doi.org\/10.1093\/advances\/nmy068 (2019).","journal-title":"Adv. Nutr."},{"key":"69559_CR65","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1038\/s41467-018-05470-4","volume":"9","author":"HM Roager","year":"2018","unstructured":"Roager, H. M. & Licht, T. R. Microbial tryptophan catabolites in health and disease. Nat Commun 9, 3294. https:\/\/doi.org\/10.1038\/s41467-018-05470-4 (2018).","journal-title":"Nat Commun"},{"key":"69559_CR66","doi-asserted-by":"publisher","first-page":"420","DOI":"10.7150\/ijbs.37421","volume":"16","author":"IW Wu","year":"2020","unstructured":"Wu, I. W. et al. Gut microbiota as diagnostic tools for mirroring disease progression and circulating nephrotoxin levels in chronic kidney disease: discovery and validation study. Int. J. Biol. Sci. 16, 420\u2013434. https:\/\/doi.org\/10.7150\/ijbs.37421 (2020).","journal-title":"Int. J. Biol. Sci."},{"key":"69559_CR67","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1007\/s00467-016-3527-x","volume":"32","author":"P Evenepoel","year":"2017","unstructured":"Evenepoel, P., Poesen, R. & Meijers, B. The gut-kidney axis. Pediatr. Nephrol. 32, 2005\u20132014. https:\/\/doi.org\/10.1007\/s00467-016-3527-x (2017).","journal-title":"Pediatr. Nephrol."},{"key":"69559_CR68","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.biopha.2017.06.066","volume":"93","author":"F Mahmoodpoor","year":"2017","unstructured":"Mahmoodpoor, F., Rahbar Saadat, Y., Barzegari, A., Ardalan, M. & Zununi Vahed, S. The impact of gut microbiota on kidney function and pathogenesis. Biomed, Pharmacother 93, 412\u2013419. https:\/\/doi.org\/10.1016\/j.biopha.2017.06.066 (2017).","journal-title":"Biomed, Pharmacother"},{"key":"69559_CR69","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/j.jchromb.2009.11.040","volume":"878","author":"K Kikuchi","year":"2010","unstructured":"Kikuchi, K. et al. Metabolomic analysis of uremic toxins by liquid chromatography\/electrospray ionization-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed Life Sci. 878, 1662\u20131668. https:\/\/doi.org\/10.1016\/j.jchromb.2009.11.040 (2010).","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed Life Sci."},{"key":"69559_CR70","first-page":"1","volume":"72","author":"T Niwa","year":"2010","unstructured":"Niwa, T. Uremic toxicity of indoxyl sulfate. Nagoya J. Med. Sci. 72, 1\u201311 (2010).","journal-title":"Nagoya J. Med. Sci."},{"key":"69559_CR71","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1681\/ASN.2011121175","volume":"23","author":"F Duranton","year":"2012","unstructured":"Duranton, F. et al. Normal and pathologic concentrations of uremic toxins. J. Am. Soc. Nephrol. 23, 1258\u20131270. https:\/\/doi.org\/10.1681\/ASN.2011121175 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"69559_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/toxins8120358","volume":"8","author":"SC Leong","year":"2016","unstructured":"Leong, S. C. & Sirich, T. L. Indoxyl Sulfate-Review of Toxicity and Therapeutic Strategies. Toxins 8, 1. https:\/\/doi.org\/10.3390\/toxins8120358 (2016).","journal-title":"Toxins"},{"key":"69559_CR73","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.2215\/CJN.03980609","volume":"4","author":"FC Barreto","year":"2009","unstructured":"Barreto, F. C. et al. Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin. J. Am. Soc. Nephrol. 4, 1551\u20131558. https:\/\/doi.org\/10.2215\/CJN.03980609 (2009).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"69559_CR74","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/jcla.20456","volume":"25","author":"CJ Lin","year":"2011","unstructured":"Lin, C. J. et al. p-Cresylsulfate and indoxyl sulfate level at different stages of chronic kidney disease. J. Clin. Lab. Anal. 25, 191\u2013197. https:\/\/doi.org\/10.1002\/jcla.20456 (2011).","journal-title":"J. Clin. Lab. Anal."},{"key":"69559_CR75","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.2215\/Cjn.11971113","volume":"9","author":"B Yu","year":"2014","unstructured":"Yu, B. et al. Serum metabolomic profiling and incident CKD among African Americans. Clin. J. Am. Soc. Nephro. 9, 1410\u20131417. https:\/\/doi.org\/10.2215\/Cjn.11971113 (2014).","journal-title":"Clin. J. Am. Soc. Nephro."},{"key":"69559_CR76","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1002\/ajh.25263","volume":"93","author":"JZ Xu","year":"2018","unstructured":"Xu, J. Z. et al. Clinical and metabolomic risk factors associated with rapid renal function decline in sickle cell disease. Am J Hematol 93, 1451\u20131460. https:\/\/doi.org\/10.1002\/ajh.25263 (2018).","journal-title":"Am J Hematol"},{"key":"69559_CR77","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1007\/s10157-011-0467-4","volume":"15","author":"T Toyohara","year":"2011","unstructured":"Toyohara, T. et al. Metabolomic profiling of the autosomal dominant polycystic kidney disease rat model. Clin. Exp. Nephrol. 15, 676\u2013687. https:\/\/doi.org\/10.1007\/s10157-011-0467-4 (2011).","journal-title":"Clin. Exp. Nephrol."},{"key":"69559_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exger.2017.10.003","volume":"100","author":"MS Lustgarten","year":"2017","unstructured":"Lustgarten, M. S. & Fielding, R. A. Metabolites related to renal function, immune activation, and carbamylation are associated with muscle composition in older adults. Exp. Gerontol. 100, 1\u201310. https:\/\/doi.org\/10.1016\/j.exger.2017.10.003 (2017).","journal-title":"Exp. Gerontol."},{"key":"69559_CR79","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12882-019-1249-6","volume":"20","author":"K Kim","year":"2019","unstructured":"Kim, K., Trott, J. F., Gao, G., Chapman, A. & Weiss, R. H. Plasma metabolites and lipids associate with kidney function and kidney volume in hypertensive ADPKD patients early in the disease course. BMC Nephrol. 20, 66. https:\/\/doi.org\/10.1186\/s12882-019-1249-6 (2019).","journal-title":"BMC Nephrol."},{"key":"69559_CR80","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess, S., Butterworth, A. & Thompson, S. G. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet. Epidemiol. 37, 658\u2013665. https:\/\/doi.org\/10.1002\/gepi.21758 (2013).","journal-title":"Genet. Epidemiol."},{"key":"69559_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani, G. et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife 7, 1. https:\/\/doi.org\/10.7554\/eLife.34408 (2018).","journal-title":"Elife"},{"key":"69559_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","volume":"32","author":"GD Smith","year":"2003","unstructured":"Smith, G. D. & Ebrahim, S. \u201cMendelian randomization\u201d: can genetic epidemiology contribute to understanding environmental determinants of disease?. Int. J. Epidemiol. 32, 1\u201322. https:\/\/doi.org\/10.1093\/ije\/dyg070 (2003).","journal-title":"Int. J. Epidemiol."},{"key":"69559_CR83","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"69559_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399406000068","volume":"8","author":"JP Ruddick","year":"2006","unstructured":"Ruddick, J. P. et al. Tryptophan metabolism in the central nervous system: medical implications. Expert Rev. Mol. Med. 8, 1\u201327. https:\/\/doi.org\/10.1017\/S1462399406000068 (2006).","journal-title":"Expert Rev. Mol. Med."},{"key":"69559_CR85","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00018-003-3161-1","volume":"61","author":"G Magni","year":"2004","unstructured":"Magni, G. et al. Enzymology of NAD`+ homeostasis in man. Cell Mol Life Sci 61, 19\u201334. https:\/\/doi.org\/10.1007\/s00018-003-3161-1 (2004).","journal-title":"Cell Mol Life Sci"},{"key":"69559_CR86","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.cmet.2013.06.013","volume":"18","author":"EP Rhee","year":"2013","unstructured":"Rhee, E. P. et al. A genome-wide association study of the human metabolome in a community-based cohort. Cell Metab. 18, 130\u2013143. https:\/\/doi.org\/10.1016\/j.cmet.2013.06.013 (2013).","journal-title":"Cell Metab."},{"key":"69559_CR87","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/ng.2982","volume":"46","author":"SY Shin","year":"2014","unstructured":"Shin, S. Y. et al. An atlas of genetic influences on human blood metabolites. Nat. Genet. 46, 543\u2013550. https:\/\/doi.org\/10.1038\/ng.2982 (2014).","journal-title":"Nat. Genet."},{"key":"69559_CR88","doi-asserted-by":"publisher","first-page":"7208","DOI":"10.1038\/ncomms8208","volume":"6","author":"HHM Draisma","year":"2015","unstructured":"Draisma, H. H. M. et al. Genome-wide association study identifies novel genetic variants contributing to variation in blood metabolite levels. Nat. Commun. 6, 7208. https:\/\/doi.org\/10.1038\/ncomms8208 (2015).","journal-title":"Nat. Commun."},{"key":"69559_CR89","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/ng.3809","volume":"49","author":"T Long","year":"2017","unstructured":"Long, T. et al. Whole-genome sequencing identifies common-to-rare variants associated with human blood metabolites. Nat. Genet. 49, 568\u2013578. https:\/\/doi.org\/10.1038\/ng.3809 (2017).","journal-title":"Nat. Genet."},{"key":"69559_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms10023","volume":"7","author":"C Pattaro","year":"2016","unstructured":"Pattaro, C. et al. Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function. Nat. Commun. 7, 1. https:\/\/doi.org\/10.1038\/ncomms10023 (2016).","journal-title":"Nat. Commun."},{"key":"69559_CR91","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck, M., Chen, C. Y., Neale, B. & Do, R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat. Genet. 50, 693\u2013698. https:\/\/doi.org\/10.1038\/s41588-018-0099-7 (2018).","journal-title":"Nat. Genet."},{"key":"69559_CR92","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1093\/bioinformatics\/btu779","volume":"31","author":"M Arnold","year":"2015","unstructured":"Arnold, M., Raffler, J., Pfeufer, A., Suhre, K. & Kastenmuller, G. SNiPA: an interactive, genetic variant-centered annotation browser. Bioinformatics 31, 1334\u20131336. https:\/\/doi.org\/10.1093\/bioinformatics\/btu779 (2015).","journal-title":"Bioinformatics"},{"key":"69559_CR93","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1038\/s41588-018-0248-z","volume":"50","author":"O Canela-Xandri","year":"2018","unstructured":"Canela-Xandri, O., Rawlik, K. & Tenesa, A. An atlas of genetic associations in UK Biobank. Nat. Genet. 50, 1593\u20131599. https:\/\/doi.org\/10.1038\/s41588-018-0248-z (2018).","journal-title":"Nat. Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-69559-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-69559-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-69559-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T10:07:49Z","timestamp":1670321269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-69559-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,29]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["69559"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-69559-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,29]]},"assertion":[{"value":"10 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12675"}}